Post‑infectious ST elevation myocardial infarction following a COVID‑19 infection: A case report

• DOI: 10.3892/br.2021.1493
• Publication Date: 2021-12-15T07:35:30Z
• Authors: Manuela Ceccarelli; Andrea Marino; Federica Cosentino; Vittoria Moscatt; Benedetto Celesia; Maria Gussio; Roberto Bruno; Emmanuele Rullo; Giuseppe Nunnari; Bruno Cacopardo
• Keywords: ST-segment elevation myocardial infarction; post-infectious sequelae; 0301 basic medicine; 0303 health sciences; 03 medical and health sciences; COVID-19; Severe Acute Respiratory Syndrome-Coronavirus-2; COVID-19; Post-infectious sequelae; Severe Acute Respiratory Syndrome-Coro-navirus-2; ST-segment elevation myocardial infarction; 3. Good health

Severe Acute Respiratory Syndrome-Coronavirus-2 (SARS-CoV-2) has been shown to increase the risk of thrombotic events due a hypercoagulable state caused by several factors. The case 59-year-old woman affected hypertension and metabolic disorders, treated for COVID-19 infection who developed cardiac symptoms during first days hospitalization is reported. Electrocardiogram analysis cardiac-ultrasound confirmed ST-segment elevation myocardial infarction (STEMI) diagnosis, thus patient underwent percutaneous coronary intervention, which was successful. This highlights possible association between respiratory infection, particularly SARS-CoV-2 cardiovascular events, in particular Coronary Syndrome. these phenomena seems related range factors, including proinflammatory hypoxemia. Moreover, amongst diseases may be also linked long-term sequelae. Thus, further studies are required better understand multifaceted severe complications this disease.